Evidence map›Paper›PMID 32511788›Full record

ArticleGenetic epidemiology2020

Power loss due to testing association between covariate-adjusted traits and genetic variants.

Pranav Yajnik, Michael Boehnke

Abstract read
In one paragraph

Article in Genetic epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pranav YajnikDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.ORCID 0000-0001-5294-4036
Michael BoehnkeDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.ORCID 0000-0002-6442-7754

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Design and Analysis of Human Gene Mapping StudiesR01HG009976 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L · 2018 to 2022
$2.5M
NHGRI NIH HHS R01 HG009976NIDDK NIH HHS P30 DK020572
6 · The paper itself

Abstract

Multiple linear regression is commonly used to test for association between genetic variants and continuous traits and estimate genetic effect sizes. Confounding variables are controlled for by including them as additional covariates. An alternative technique that is increasingly used is to regress out covariates from the raw trait and then perform regression analysis with only the genetic variants included as predictors. In the case of single-variant analysis, this adjusted trait regression (ATR) technique is known to be less powerful than the traditional technique when the genetic variant is correlated with the covariates We extend previous results for single-variant tests by deriving exact relationships between the single-variant score, Wald, likelihood-ratio, and F test statistics and their ATR analogs. We also derive the asymptotic power of ATR analogs of the multiple-variant score and burden tests. We show that the maximum power loss of the ATR analog of the multiple-variant score test is completely characterized by the canonical correlations between the set of genetic variants and the set of covariates. Further, we show that for both single- and multiple-variant tests, the power loss for ATR analogs increases with increasing stringency of Type 1 error control (

Indexed as

Genetic VariationGenome-Wide Association StudyModels, GeneticQuantitative Trait, HeritableHumansLeast-Squares AnalysisLinear ModelsPhenotypeadjusted outcomecovariatesgenome-wide association studylinear regressionpower loss

Identifiers

PMID32511788
PMCPMC7610149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.